Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
49.1 EUR | +1.03% | +9.01% | -34.59% |
06-07 | Cytokinetics Insider Sold Shares Worth $1,099,125, According to a Recent SEC Filing | MT |
06-05 | Sector Update: Health Care Stocks Advance Late Afternoon | MT |
Evolution of the average Target Price on Cytokinetics, Incorporated
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Cytokinetics, Incorporated
B. Riley | |
Truist Securities | |
JMP Securities | |
Raymond James | |
Needham & Co. | |
Oppenheimer | |
Mizuho Securities | |
UBS | |
Cantor Fitzgerald | |
HC Wainwright | |
Goldman Sachs | |
SVB Securities LLC | |
JPMorgan Chase | |
BofA Securities | |
Morgan Stanley | |
Piper Sandler | |
Jefferies & Co. | |
Barclays | |
Wolfe Research |
EPS Revisions
- Stock Market
- Equities
- CYTK Stock
- KK3A Stock
- Consensus Cytokinetics, Incorporated